Logo image of ENVIP.OL

ENVIPCO HOLDING NV (ENVIP.OL) Stock Fundamental Analysis

OSL:ENVIP - Euronext Oslo - NL0015000GX8 - Common Stock - Currency: NOK

65  -1.8 (-2.69%)

Fundamental Rating

4

Overall ENVIP gets a fundamental rating of 4 out of 10. We evaluated ENVIP against 111 industry peers in the Machinery industry. ENVIP scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ENVIP has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ENVIP has reported negative net income.
ENVIP had a positive operating cash flow in the past year.
In multiple years ENVIP reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: ENVIP reported negative operating cash flow in multiple years.
ENVIP.OL Yearly Net Income VS EBIT VS OCF VS FCFENVIP.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

With a Return On Assets value of -2.64%, ENVIP is not doing good in the industry: 74.77% of the companies in the same industry are doing better.
ENVIP has a Return On Equity of -4.91%. This is in the lower half of the industry: ENVIP underperforms 73.87% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.40%, ENVIP is doing worse than 73.87% of the companies in the same industry.
Industry RankSector Rank
ROA -2.64%
ROE -4.91%
ROIC 1.4%
ROA(3y)-1.73%
ROA(5y)-1.7%
ROE(3y)-4.84%
ROE(5y)-4.16%
ROIC(3y)N/A
ROIC(5y)N/A
ENVIP.OL Yearly ROA, ROE, ROICENVIP.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

Looking at the Operating Margin, with a value of 1.30%, ENVIP is doing worse than 75.68% of the companies in the same industry.
Looking at the Gross Margin, with a value of 37.08%, ENVIP is in line with its industry, outperforming 45.95% of the companies in the same industry.
In the last couple of years the Gross Margin of ENVIP has remained more or less at the same level.
Industry RankSector Rank
OM 1.3%
PM (TTM) N/A
GM 37.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.6%
GM growth 5Y-0.44%
ENVIP.OL Yearly Profit, Operating, Gross MarginsENVIP.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ENVIP is destroying value.
Compared to 1 year ago, ENVIP has more shares outstanding
ENVIP has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ENVIP has an improved debt to assets ratio.
ENVIP.OL Yearly Shares OutstandingENVIP.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ENVIP.OL Yearly Total Debt VS Total AssetsENVIP.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

ENVIP has an Altman-Z score of 4.43. This indicates that ENVIP is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ENVIP (4.43) is better than 92.79% of its industry peers.
A Debt/Equity ratio of 0.13 indicates that ENVIP is not too dependend on debt financing.
ENVIP has a better Debt to Equity ratio (0.13) than 81.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z 4.43
ROIC/WACC0.19
WACC7.34%
ENVIP.OL Yearly LT Debt VS Equity VS FCFENVIP.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

ENVIP has a Current Ratio of 2.03. This indicates that ENVIP is financially healthy and has no problem in meeting its short term obligations.
ENVIP's Current ratio of 2.03 is fine compared to the rest of the industry. ENVIP outperforms 73.87% of its industry peers.
ENVIP has a Quick Ratio of 1.25. This is a normal value and indicates that ENVIP is financially healthy and should not expect problems in meeting its short term obligations.
ENVIP has a Quick ratio of 1.25. This is in the better half of the industry: ENVIP outperforms 69.37% of its industry peers.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 1.25
ENVIP.OL Yearly Current Assets VS Current LiabilitesENVIP.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

6

3. Growth

3.1 Past

ENVIP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -162.50%.
The Revenue has been growing slightly by 6.47% in the past year.
ENVIP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.59% yearly.
EPS 1Y (TTM)-162.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1829.17%
Revenue 1Y (TTM)6.47%
Revenue growth 3Y45.27%
Revenue growth 5Y26.59%
Sales Q2Q%-23.46%

3.2 Future

ENVIP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 379.32% yearly.
The Revenue is expected to grow by 50.92% on average over the next years. This is a very strong growth
EPS Next Y1528%
EPS Next 2Y634.98%
EPS Next 3Y379.32%
EPS Next 5YN/A
Revenue Next Year32.37%
Revenue Next 2Y43.56%
Revenue Next 3Y50.92%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ENVIP.OL Yearly Revenue VS EstimatesENVIP.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
ENVIP.OL Yearly EPS VS EstimatesENVIP.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2019 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6 0.8 1

4

4. Valuation

4.1 Price/Earnings Ratio

ENVIP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
ENVIP is valuated reasonably with a Price/Forward Earnings ratio of 10.83.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ENVIP indicates a somewhat cheap valuation: ENVIP is cheaper than 64.86% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ENVIP to the average of the S&P500 Index (22.15), we can say ENVIP is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 10.83
ENVIP.OL Price Earnings VS Forward Price EarningsENVIP.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

ENVIP's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ENVIP is more expensive than 75.68% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 31.68
ENVIP.OL Per share dataENVIP.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ENVIP's earnings are expected to grow with 379.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y634.98%
EPS Next 3Y379.32%

0

5. Dividend

5.1 Amount

ENVIP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ENVIPCO HOLDING NV

OSL:ENVIP (5/30/2025, 7:00:00 PM)

65

-1.8 (-2.69%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)08-13 2025-08-13
Inst Owners27.13%
Inst Owner ChangeN/A
Ins Owners35.17%
Ins Owner ChangeN/A
Market Cap3.75B
Analysts85.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-53.1%
Min EPS beat(2)-75.49%
Max EPS beat(2)-30.72%
EPS beat(4)0
Avg EPS beat(4)-101.06%
Min EPS beat(4)-149.02%
Max EPS beat(4)-30.72%
EPS beat(8)3
Avg EPS beat(8)-46.73%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-8.69%
Min Revenue beat(2)-24.86%
Max Revenue beat(2)7.48%
Revenue beat(4)1
Avg Revenue beat(4)-9.89%
Min Revenue beat(4)-24.86%
Max Revenue beat(4)7.48%
Revenue beat(8)3
Avg Revenue beat(8)-2.71%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-48.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.56%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.83
P/S 2.92
P/FCF N/A
P/OCF 144.8
P/B 5.05
P/tB 6.53
EV/EBITDA 31.68
EPS(TTM)-0.58
EYN/A
EPS(NY)6
Fwd EY9.24%
FCF(TTM)-0.9
FCFYN/A
OCF(TTM)0.45
OCFY0.69%
SpS22.29
BVpS12.87
TBVpS9.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.64%
ROE -4.91%
ROCE 1.82%
ROIC 1.4%
ROICexc 1.88%
ROICexgc 2.5%
OM 1.3%
PM (TTM) N/A
GM 37.08%
FCFM N/A
ROA(3y)-1.73%
ROA(5y)-1.7%
ROE(3y)-4.84%
ROE(5y)-4.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.6%
GM growth 5Y-0.44%
F-Score6
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA 0.83
Cap/Depr 76.62%
Cap/Sales 6.04%
Interest Coverage 250
Cash Conversion 21.93%
Profit Quality N/A
Current Ratio 2.03
Quick Ratio 1.25
Altman-Z 4.43
F-Score6
WACC7.34%
ROIC/WACC0.19
Cap/Depr(3y)125.69%
Cap/Depr(5y)118.36%
Cap/Sales(3y)9.77%
Cap/Sales(5y)10.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-162.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1829.17%
EPS Next Y1528%
EPS Next 2Y634.98%
EPS Next 3Y379.32%
EPS Next 5YN/A
Revenue 1Y (TTM)6.47%
Revenue growth 3Y45.27%
Revenue growth 5Y26.59%
Sales Q2Q%-23.46%
Revenue Next Year32.37%
Revenue Next 2Y43.56%
Revenue Next 3Y50.92%
Revenue Next 5YN/A
EBIT growth 1Y-74.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year345.56%
EBIT Next 3Y142.35%
EBIT Next 5YN/A
FCF growth 1Y86.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y109.23%
OCF growth 3Y34.86%
OCF growth 5Y8.65%